SC 13G: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker: PACB · Form: SC 13G · Filed: Nov 26, 2024 · CIK: 1299130

Sentiment: neutral

Topics: sc-13g

AI Summary

SC 13G filing by PACIFIC BIOSCIENCES OF CALIFORNIA, INC..

Risk Assessment

Risk Level: low

Filing Stats: 1,427 words · 6 min read · ~5 pages · Grade level 11.1 · Accepted 2024-11-26 20:27:01

Key Financial Figures

Filing Documents

From the Filing

SC 13G 1 ef20039294_sc13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * Pacific Biosciences of California, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 69404D108 (CUSIP Number) November 21, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 69404D108 Schedule 13G Page 1 of 6 Pages 1 NAMES OF REPORTING PERSONS SB Northstar LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 20,451,570 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 20,451,570 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 20,451,570 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.5%* 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN * Based on the sum of (i) 273,863,544 shares of common stock outstanding as of October 31, 2024, as provided in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2024 and (ii) 20,451,570 shares of common stock issued to the SB Northstar LP on November 21, 2024. CUSIP No. 69404D108 Schedule 13G Page 2 of 6 Pages 1 NAMES OF REPORTING PERSONS Silver Brick Management PTE. LTD. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Singapore NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 20,451,570 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 20,451,570 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 20,451,570 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.5%* 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO * Based on the sum of (i) 273,863,544 shares of common stock outstanding as of October 31, 2024, as provided in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2024 and (ii) 20,451,570 shares of common stock issued to the SB Northstar LP on November 21, 2024. CUSIP No. 69404D108 Schedule 13G Page 3 of 6 Pages 1 NAMES OF REPORTING PERSONS SoftBank Group Corp. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Japan NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 20,451,570 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 20,451,570 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 20,451,570 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.5%* 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO * Based on the sum of (i) 273,863,544 shares of common stock outstanding as of October 31, 2024, as provided in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2024 and (ii) 20,451,570 shares of common stock issued to the SB Northstar LP on November 21, 2024. CUSIP No. 69404D108 Schedule 13G Page 4 of 6 Pages Item 1. (a) Name of issuer: Pacific Biosciences of California, Inc. (b) Address of issuer's principal executive offices: 1305 O'Brien Drive Menlo Park, California 94025 Item 2. (a) Name of person filing: This Statement is filed on behalf of SB Northstar LP, Silver Brick Management PTE. LTD. ("Silver Brick") and SoftBank Group Corp. ("SoftBank"). The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The common stock reported herein is held by SB Northstar LP. SoftBank is the parent company of Silver Brick, which has been appointed as investment manager of SB Northstar LP and is responsible for making

View Full Filing

View this SC 13G filing on SEC EDGAR

View on Read The Filing